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Wonnapinij et al., page 540
Heteroplasmy most often refers to a single cell that
contains more than one type of mtDNA. In the case of
inherited mtDNA mutations, different cells and tissues
throughout the body vary in their degree of heteroplasmy.
For example, the load of mutant mtDNA may be great in
hematopoietic cells but nearly absent in skeletal muscle.
Likewise, some hematopoietic cells may have an abun-
dance of mutant mtDNA, whereas others may have less
or even lack mutant mtDNA. This variability is also true
for cells in the germ line, leading to a great deal of variance
in the degree of inherited heteroplasmy, even in siblings
with the same affected mother. To date, this variance has
made it difﬁcult for physicians and genetics counselors
to predict the likelihood of mitochondrial disease trans-
mission. Here, Wonnapinij and colleagues introduce a
method for determining the standard error of variance
and determine the necessary number of cells in which
heteroplasmy is measured to accurately estimate mtDNA
mutation-level variance. They ﬁnd that most studies are
underpowered to draw reliable conclusions regarding the
mtDNAmutation level because not enoughmeasurements
of heteroplasmy are made. They suggest that more than
30 measurements are required for detecting a 2-fold (or
greater) difference in variance for mutation levels near
50%, and they recommend 50 or more measurements for
detecting mutation levels on both the low (10%) and
high (90%) ends of the spectrum. Furthermore, these
authors ﬁnd the variance of heteroplasmy in humans to
be greater than that in mice. These results can be used to
shed further light on the size and timing of the mtDNA
bottleneck.Mutations in FKBP10, which Encodes FKBP65,
Cause Osteogenesis Imperfecta
Alanay et al., page 551
The brittle-bone disease osteogenesis imperfecta (OI) is
caused by the disruption of the process in which type I
procollagen is modiﬁed and converted to type I collagen,
which is then deposited into the extracellular matrix. The
disease is very heterogeneous, both in terms of pheno-
typic severity and in the types of genes in which muta-1Science Editor, AJHG; 2Deputy Editor, AJHG
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due to mutations in the genes encoding type I procolla-
gen, dysfunctional chaperon proteins and proteins
involved in modiﬁcation of the collagen chains can also
lead to disease. In this issue, Alanay and colleagues report
the results of their gene-mapping study in families with
a severe and progressively deforming type of OI. The
authors identify mutations in FKBP10, the gene encoding
FKBP65, in their families. FKBP65 is a member of a family
of proteins with chaperon function, and the protein was
previously shown to interact with type I procollagen.
Functional work with patient samples demonstrates that
the mutations do not affect posttranslational processing
of type I procollagens and collagens but result in a defect
in protein secretion.Genetic-Association Studies Using Electronic
Medical Record Data
Ritchie et al., page 560
It is well accepted that using larger sample sizes in asso-
ciation studies will yield more power, but collecting addi-
tional cases and controls is not a trivial task. One possible
source of such data may be DNA databanks that are linked
to electronic medical record (EMR) systems. EMRs were
created to improve patient care through improving the
accessibility and organization of vast amounts of patient
data; therefore, these EMRs potentially contain the infor-
mation necessary to designate whether someone could
be a case or control in a study. If the EMRs were then
connected to a biorepository containing DNA that could
be genotyped, these samples could serve as members of
association-study data sets. A ﬁrst step in the development
of such a resource is establishing whether the phenotype-
data contained in the EMRs are comprehensive and
speciﬁc enough for genetic-association analyses. In this
issue, Ritchie and colleagues evaluate whether validated
genetic associations can be identiﬁed in the samples
from a DNA databank linked to EMR data. They genotype
their samples for variants known to be associated with
atrial ﬁbrillation, Crohn disease, multiple sclerosis, rheu-
matoid arthritis, and type 2 diabetes. Cases and controls
for each disease are then selected on the basis of classiﬁca-
tions used in the EMRs. The authors report that, of the
associations for which they had enough power to observeGenetics. All rights reserved.
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a signiﬁcant signal, the majority of known associations are
replicated. These results suggest that the data from EMRs
and biorepositories might serve as a valuable resource for
genetic-association studies.Integrating GWAS Pathway Analyses with
Genetics of Gene Expression Data
Zhong et al., page 581
Genetics of gene expression (GGE) studies are studies in
which SNPs associated with gene expression are identiﬁed.
These expression SNPs, or eSNPs, might be found within or
near the gene whose expression level they are modifying,
or they could affect gene expression from afar via more
indirect mechanisms. Either way, these eSNPs are likely
to be biologically relevant and are potentially strong candi-
dates for association with disease. In this issue, Zhong and
colleagues integrate GGE data into GWAS pathway anal-
yses to identify variants that are associated with type 2
diabetes (T2D). They start by creating a list of genes whose
expression levels are affected by eSNPs. These genes are
assigned to pathways, and the eSNPs that are associated
with the expression of the genes are grouped together.
These groups of eSNPs are then evaluated for determining
whether they are associated with T2D. The idea is that, if
they are, the gene pathway that they represent is likely
relevant to disease etiology. By analyzing data from the
Wellcome Trust Case Control Cohort and the Diabetes
Genetics Replication and Meta-analysis Consortium, the
authors provide support for pathways that have been
previously implicated in T2D and identify additional
pathways whose involvement in the disease has yet to be
reported.502 The American Journal of Human Genetics 86, 501–502, April 9, 2Gender-Biased Admixture in the SAC Population
Quintana-Murci et al., page 611
South Africa comprises separate groups of people having
distinct geographic and genetic histories. Nearly 80% of
the South African population is black and represents a
multitude of ethnicities speaking a number of different
languages. Around 10% of the South African population
consists of white individuals. This group has a predomi-
nantly European background derived from settlers of the
1600s, and coloured individuals make up around 9% of
the South African population. The South African Coloured
(SAC) population is thought to be derived from these early
European settlers, their slaves, and native people of South
Africa, which make up the remaining 1%–2% of the
South African population. The SAC population has among
the highest degree of recent admixture. Here, usingmarkers
from mtDNA and the nonrecombining portion of the
Y chromosome (NRY), Quintana-Murci and colleagues
examine thematernal andpaternal componentsof theSAC.
Their ﬁndings reveal a strong gender bias in SAC admixture,
with very little mtDNA derived from Europeans but most of
the NRY markers contributed by Europeans. These data indi-
cate the ancestry of the SAC population is largely derived
from English men and African and Southeast Asian women.
Thisgeneticdataﬁtswellwithhistoricalaccountsof theorigins
of contemporary South Africa. History tells us that in 1652,
a post was established at Table Bay to provide refreshments
for sailors of the Dutch East India Company and that Cape
Town soon became an outstation of this company. This led
to European settlers, predominantlymen, who brought along
slaves, often from Southeast Asia. Combining such historical
and genetic data helps to promote an understanding of the
diversity and dynamics of admixed populations.010
